Healthcare >> CEO Interviews >> May 24, 2016
Brian A. Leuthner has been the Co-Founder, President and Chief Executive Officer of Edge Therapeutics, Inc., since its inception, and also serves on the company’s board of directors. He has more than 25 years of experience in the hospital acute care marketplace, with a specific expertise in critical care and neurocritical care. Prior to founding Edge, Mr. Leuthner was the CEO of Fontus Pharmaceuticals, the Senior Head of Marketing for The Medicines Company and the Director of Market Development for ESP Pharma. He also held marketing and sales positions of significant responsibility at Burroughs Wellcome, GlaxoWellcome and Ortho Biotech. In these leadership roles, he helped create and advance hospital business units, develop and launch new critical care products, and strengthen customer relationships. Mr. Leuthner received his B.S. and MBA degrees from the University of North Carolina at Chapel Hill. Profile
TWST: If you would, please start by introducing our readers to Edge Therapeutics with the company's history.
Mr. Leuthner: We started Edge Therapeutics in 2009.